Login Form

To learn more about participating in one of these studies please contact a research coordinator at 206-315-0371. You can also click the enrollment button next to the study you are interested in. Check back often as existing studies will close when fully enrolled and new studies will become available.


Drug/Criteria Diagnosis Age Enroll
Athenex KX01-AK-003
  • Actinic Keratosis on face or scalp
  • Male or Female
  • A treatment area on the face or scalp that contains 4 to 8 clinically typical, visible, and discrete AK lesions
  • Willing to avoid excessive sun or UV exposure
  • KX2-391 Ointment 1% vs. placebo
Actinic Keratosis  18 years and older



Leo Pharma LP0162-1325
  • Male or Female
  • Moderate to severe
  • BSA of ≥10%
  • EASI score of ≥12 and IGA score of ≥3
  • Tralokinumab vs. placebo
Atopic Dermatitis  18 years and older



(206) 267 2100 (206) 267 2100

Monday - Friday 7:30am to 5:30pm
1730 Minor Avenue, Suite 1000 Seattle, WA 98101